Ngā hua rapu - Frederik Marmé
- E whakaatu ana i te 1 - 20 hua o te 77
- Haere ki te Whārangi Whai Ake
-
1
Targeted Therapies in Triple-Negative Breast Cancer mā Frederik Marmé, Andreas Schneeweiß
I whakaputaina 2015Revisão -
2
-
3
-
4
Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS) mā Joerg Heil, Simone Holl, Michael Golatta, Geraldine Rauch, Joachim Rom, Frederik Marmé, Gerhard Gebauer, Christof Sohn
I whakaputaina 2010Artigo -
5
The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction mā Eva Koellensperger, Lilly-Claire Bonnert, Inka Zoernig, Frederik Marmé, Stefanie Sandmann, Günter Germann, Felix Gramley, Uwe Leimer
I whakaputaina 2017Artigo -
6
-
7
Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites mā Marion Ott, Frederik Marmé, Gerhard Moldenhauer, Horst Lindhofer, Michael Hennig, R. Spannagl, Mirko M. Essing, R. Linke, Diane Seimetz
I whakaputaina 2011Artigo -
8
Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis mā Glen Kristiansen, Eda Machado, Niko P. Bretz, Christian Rupp, Klaus‐Jürgen Winzer, Anne-Kathleen König, Gerhard Moldenhauer, Frederik Marmé, Júlia Costa, Peter Altevogt
I whakaputaina 2010Artigo -
9
Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re Therapy mā Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratochwil, Frederik L. Giesel, Walter Mier, Frederik Marmé, Jürgen Debus, Uwe Haberkorn
I whakaputaina 2020Artigo -
10
Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial mā Hope S. Rugo, Peter Schmid, Sara M. Tolaney, Florence Dalenc, Frederik Marmé, Ling Shi, Wendy Verret, Anuj Shah, Mahdi Gharaibeh, Aditya Bardia, Javier Cortés
I whakaputaina 2024Artigo -
11
Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer mā Hope S. Rugo, Aditya Bardia, Peter Schmid, Sara M. Tolaney, Anandaroop Dasgupta, Ankita Kaushik, Wendy Verret, Marine Gosset, Adam Brufsky, Javier Cortés, Frederik Marmé
I whakaputaina 2025Artigo -
12
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention mā Anastasia Loktev, Thomas Lindner, Eva-Maria Burger, Annette Altmann, Frederik L. Giesel, Clemens Kratochwil, Jürgen Debus, Frederik Marmé, Dirk Jäger, Walter Mier, Uwe Haberkorn
I whakaputaina 2019Artigo -
13
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade mā André Hennigs, Fabian Riedel, Frederik Marmé, Hans‐Peter Sinn, Katja Lindel, Ádám Gondos, Katharina Smetanay, Michael Golatta, Christof Sohn, Florian Schuetz, Joerg Heil, Andreas Schneeweiß
I whakaputaina 2016Artigo -
14
Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling mā Niko P. Bretz, Johannes Ridinger, Anne-Kathleen Rupp, Katharina Rimbach, Sascha Keller, Christian Rupp, Frederik Marmé, Ludmila Umansky, Viktor Umansky, Tatjana Eigenbrod, Marei Sammar, Peter Altevogt
I whakaputaina 2013Artigo -
15
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer mā Hans‐Peter Sinn, Andreas Schneeweiß, Marius Keller, Kornelia Schlombs, Mark Laible, Julia Seitz, Sotirios Lakis, Elke Veltrup, Peter Altevogt, Sebastian Eidt, Ralph M. Wirtz, Frederik Marmé
I whakaputaina 2017Artigo -
16
TROPiCS-02: A Phase III Study Investigating Sacituzumab Govitecan in the Treatment of HR+/HER2- Metastatic Breast Cancer mā Hope S. Rugo, Aditya Bardia, Sara M. Tolaney, Carlos L. Arteaga, Javier Cortés, Joohyuk Sohn, Frederik Marmé, Quan Hong, Rosemary Delaney, Amir Hafeez, Fabrice André, Peter Schmid
I whakaputaina 2020Artigo -
17
Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer mā Katarina Ćuk, Manuela Zucknick, Dharanija Madhavan, Sarah Schott, Michael Golatta, Jörg Heil, Frederik Marmé, Andrey Turchinovich, Hans‐Peter Sinn, Christof Sohn, H. Junkermann, Andreas Schneeweiß, Barbara Burwinkel
I whakaputaina 2013Artigo -
18
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study mā André Hennigs, Fabian Riedel, Ádám Gondos, Hans‐Peter Sinn, Peter Schirmacher, Frederik Marmé, Dirk Jäger, Hans‐Ulrich Kauczor, Anne Stieber, Katja Lindel, Jürgen Debus, Michael Golatta, Florian Schütz, Christof Sohn, Jörg Heil, Andreas Schneeweiß
I whakaputaina 2016Artigo -
19
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN st... mā Jenny Furlanetto, W. Eiermann, Frederik Marmé, Toralf Reimer, Mattea Reinisch, Sabine Schmatloch, Elmar Stickeler, Christoph Thomssen, Michael Untch, Carsten Denkert, Gϋnter von Minckwitz, Bianca Lederer, Valentina Nekljudova, Karsten E. Weber, Sibylle Loibl, Volker Möbus
I whakaputaina 2016Artigo -
20
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicent... mā Peter Hillemanns, Michal Zikán, Frédéric Forget, Hannelore Denys, Jean‐François Baurain, Lukáš Rob, Linn Woelber, Paweł Blecharz, Mariusz Bidziński, Josef Chovanec, Frederik Marmé, Theresa Link, Christian Dannecker, Anders Rosholm, Kaja C. G. Berg, Roberto S Oliveri, Kristina Lindemann
I whakaputaina 2025Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Internal medicine
Medicine
Oncology
Breast cancer
Biology
Gene
Genetics
Chemotherapy
Cancer research
Ovarian cancer
Metastatic breast cancer
Biochemistry
Clinical trial
Surgery
Clinical endpoint
Genotype
Gynecology
Immunology
Pathology
Chemistry
Cisplatin
Confidence interval
Disease
Adverse effect
Alternative medicine
Carboplatin
Computational biology
Environmental health
Hazard ratio